Harmony Biosciences Hldgs (HRMY) Stock Price, Quote, News & History | Benzinga

Harmony Biosciences Holdings Inc (HRMY) Stock Price, Quote, News & History

HRMYNASDAQ

Trade with Public

Trade with Public

$42.86

1.613.9%

At close: Sep 1, 5:00 PM EST

$43.02

1.774.3%

Pre-Market: 5:37 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$42.86

Volume / Avg.

1.13K / 815.52K

Day Range

- - -

52 Wk Range

25.52 - 43.02

Market Cap

$2.51B

P/E Ratio

13.88

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

9.49%

Days to Cover

4.77

Recent Harmony Biosciences Holdings, Inc. News

This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Consider ACMR stock: analysts' thoughts

Avi Kapoor

Harmony Biosciences Says New Data Supports Neurology Pipeline

Harmony Biosciences stock jumped after record Q2 revenue, an earnings beat, strong WAKIX sales and updated analyst price targets.

Vandana Singh

CAVA Group To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Top 3 Health Care Stocks That Are Preparing To Pump In Q4

Avi Kapoor

Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

355.08M

Investing Cash Flow (TTM)

-337.57M

Financing Cash Flow (TTM)

-13.79M

Free Cash Flow (TTM)

354.90M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

3.72M

Analyst Trends and Forecast

0

0

0

0

May

0

0

0

0

Jun

2

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.98B

PE Ratio (TTM)

13.88

PE Ratio (FWD)

10.65

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.62

PB Ratio (TTM)

2.50

Earnings Yield % (TTM)

7.21%

Earnings Yield % (FWD)

9.39%

EV / EBITDA (TTM)

7.08

Price / EBITDA (TTM)

8.99

Price / Free Cash Flow (TTM)

7.09

Book Value / Share

$17.16

Company Debt

Total Debt

$153.96M

LT Debt

$133.96M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$18.75M

Total Cash

$549.77M

Debt to Equity

0.15

Issuance of Debt (TTM)

-$18.75M

Repayment of Debt (TTM)

-$18.75M

Key Statistics

Open

-

Close

$42.86

Volume / Avg.

1.13K / 815.52K

Day Range

- - -

52 Wk Range

25.52 - 43.02

Market Cap

$2.51B

P/E Ratio

13.88

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

9.49%

Days to Cover

4.77

About

Sector

Health Care

Industry

Pharmaceuticals

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Harmony Biosciences Hldgs (HRMY) stock?

A

You can purchase shares of Harmony Biosciences Hldgs (NASDAQ:HRMY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Harmony Biosciences Hldgs (HRMY) competitors?

A

Other companies in Harmony Biosciences Hldgs’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Harmony Biosciences Hldgs (HRMY) stock?

A

Harmony Biosciences Hldgs has a consensus price target of $47.94.

Q

What is the current price for Harmony Biosciences Hldgs (HRMY)?

A

The stock price for Harmony Biosciences Hldgs (NASDAQ: HRMY) is $43.0239 last updated September 3, 2026 at 8:13 AM EDT.

Q

Does Harmony Biosciences Hldgs (HRMY) pay a dividend?

A

There are no upcoming dividends for Harmony Biosciences Hldgs.

Q

When is Harmony Biosciences Hldgs (NASDAQ:HRMY) reporting earnings?

A

Harmony Biosciences Hldgs does not have any upcoming earnings scheduled.

Q

Is Harmony Biosciences Hldgs (HRMY) going to split?

A

There is no upcoming split for Harmony Biosciences Hldgs.

Q

What sector and industry does Harmony Biosciences Hldgs (HRMY) operate in?

A

Harmony Biosciences Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.